metacrine.comHealthcareFounded: 2014Funding to Date: $134.77MM
Metacrine is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal (GI) diseases.
For more details on financing and valuation for Metacrine, register or login.
View Enterprise Value for Metacrine.
To read this article and more news on Metacrine, register or login.